Abstract
Anti-ribosomal P protein antibody (anti-P) in cerebral spinal fluids (CSF) has been reported to associate with NPSLE and IgG anti-P in CSF was suggested to be a useful marker for the diagnosis of neuropsychiatric syndromes of systemic lupus erythematosus (NPSLE). There is growing evidence that chemokines, such as MCP-1/CCL2 and IP- 10/CXCL10 are involved in the pathogenesis of NPSLE. To study the relationship between these markers in CSF from pa- tients with NPSLE, we measured the levels of IgG anti-P, MCP-1/CCL2 and IP-10/CXCL10 in the same samples. We found no correlations between the titer of IgG anti-P antibody and IP-10/CXCL10 or MCP-1/CCL2, suggesting that IgG anti-P antibody and chemokine levels might discriminate the different subset of NPSLE symptoms.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
